Product Details for NDA 009866
SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE)
EQ 100MG BASE/VIAL
Marketing Status: Prescription
EQ 250MG BASE/VIAL
Marketing Status: Prescription
EQ 500MG BASE/VIAL
Marketing Status: Prescription
EQ 1GM BASE/VIAL
Marketing Status: Prescription
EQ 100MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: HYDROCORTISONE SODIUM SUCCINATE
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 100MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE)
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 100MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 250MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: HYDROCORTISONE SODIUM SUCCINATE
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 250MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE)
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 250MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 500MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: HYDROCORTISONE SODIUM SUCCINATE
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE)
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 1GM BASE/VIAL
Marketing Status: Prescription
Active Ingredient: HYDROCORTISONE SODIUM SUCCINATE
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: SOLU-CORTEF
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N009866
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Prescription
Patent and Exclusivity Information